Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAVS Antikörper (AA 1-65)

Der Kaninchen Polyklonal Anti-MAVS-Antikörper wurde für ELISA validiert. Er ist geeignet, MAVS in Proben von Human zu detektieren.
Produktnummer ABIN7159830

Kurzübersicht für MAVS Antikörper (AA 1-65) (ABIN7159830)

Target

Alle MAVS Antikörper anzeigen
MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))

Reaktivität

  • 46
  • 36
  • 7
  • 2
  • 1
Human

Wirt

  • 66
  • 8
Kaninchen

Klonalität

  • 68
  • 6
Polyklonal

Konjugat

  • 41
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser MAVS Antikörper ist unkonjugiert

Applikation

  • 67
  • 28
  • 16
  • 16
  • 13
  • 13
  • 13
  • 10
  • 7
  • 4
  • 2
  • 2
  • 1
  • 1
ELISA
  • Bindungsspezifität

    • 15
    • 8
    • 8
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-65

    Kreuzreaktivität

    Human

    Aufreinigung

    Antigen Affinity Purified

    Immunogen

    Recombinant Human Mitochondrial antiviral-signaling protein (1-65AA)

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))

    Andere Bezeichnung

    MAVS

    Hintergrund

    Background: Required for innate immune defense against viruses. Acts downstream of DDX58/RIG-I and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFN-beta and RANTES (CCL5). Peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. May activate the same pathways following detection of extracellular dsRNA by TLR3. May protect cells from apoptosis.

    Aliases: CARD adapter inducing interferon beta antibody, CARD adaptor inducing IFN beta antibody, Cardif antibody, DKFZp666M015 antibody, FLJ27482 antibody, FLJ41962 antibody, IFN B promoter stimulator 1 antibody, Interferon beta promoter stimulator protein 1 antibody, Ips 1 antibody, IPS-1 antibody, Ips1 antibody, KIAA1271 antibody, MAVS antibody, MAVS_HUMAN antibody, Mitochondrial anti viral signaling protein antibody, Mitochondrial Antiviral Signaling antibody, Mitochondrial antiviral signaling protein antibody, Mitochondrial antiviral-signaling protein antibody, Putative NF kappa B activating protein 031N antibody, Putative NF-kappa-B-activating protein 031N antibody, Virus induced signaling adapter antibody, virus induced signaling adaptor antibody, Virus-induced-signaling adapter antibody, VISA antibody

    UniProt

    Q7Z434

    Pathways

    Activation of Innate immune Response, Inositol Metabolic Process, Hepatitis C
Sie sind hier:
Chat with us!